These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
656 related articles for article (PubMed ID: 29545802)
1. Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation. Litjens NHR; van der Wagen L; Kuball J; Kwekkeboom J Front Immunol; 2018; 9():389. PubMed ID: 29545802 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985 [TBL] [Abstract][Full Text] [Related]
3. Expansion of effector memory Vδ2 Huang Y; Jiang C; Zhu J; Lin L; Mao M; Yin T; Cai G Front Immunol; 2024; 15():1397483. PubMed ID: 38915409 [TBL] [Abstract][Full Text] [Related]
4. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation. Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275 [TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus: an unlikely ally in the fight against blood cancers? Bigley AB; Baker FL; Simpson RJ Clin Exp Immunol; 2018 Sep; 193(3):265-274. PubMed ID: 29737525 [TBL] [Abstract][Full Text] [Related]
6. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation. Davis ZB; Cooley SA; Cichocki F; Felices M; Wangen R; Luo X; DeFor TE; Bryceson YT; Diamond DJ; Brunstein C; Blazar BR; Wagner JE; Weisdorf DJ; Horowitz A; Guethlein LA; Parham P; Verneris MR; Miller JS Biol Blood Marrow Transplant; 2015 Sep; 21(9):1653-62. PubMed ID: 26055301 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation. Minculescu L; Sengelov H; Marquart HV; Ryder LP; Fischer-Nielsen A; Haastrup E Front Immunol; 2021; 12():625165. PubMed ID: 33777007 [TBL] [Abstract][Full Text] [Related]
8. Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation. Jin F; Lin H; Gao S; Wang H; Yan H; Guo J; Hu Z; Jin C; Wang Y; Wang Z; Zhao Y; Liu Y; Zheng X; Tan Y; Li W; Dai Y; Yang Y Oncotarget; 2017 Jan; 8(1):51-63. PubMed ID: 27980216 [TBL] [Abstract][Full Text] [Related]
9. Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children. Jeljeli M; Guérin-El Khourouj V; Porcher R; Fahd M; Leveillé S; Yakouben K; Ouachée-Chardin M; LeGoff J; Cordeiro DJ; Pédron B; Baruchel A; Dalle JH; Sterkers G Br J Haematol; 2014 Jul; 166(2):229-39. PubMed ID: 24702221 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen. Manjappa S; Bhamidipati PK; Stokerl-Goldstein KE; DiPersio JF; Uy GL; Westervelt P; Liu J; Schroeder MA; Vij R; Abboud CN; Fehniger TA; Cashen AF; Pusic I; Jacoby M; Meera SJ; Romee R Biol Blood Marrow Transplant; 2014 Jan; 20(1):46-52. PubMed ID: 24120526 [TBL] [Abstract][Full Text] [Related]
11. Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies. Muccio L; Bertaina A; Falco M; Pende D; Meazza R; Lopez-Botet M; Moretta L; Locatelli F; Moretta A; Della Chiesa M Haematologica; 2016 Mar; 101(3):371-81. PubMed ID: 26659918 [TBL] [Abstract][Full Text] [Related]
12. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia. Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229 [TBL] [Abstract][Full Text] [Related]
13. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation. Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981 [TBL] [Abstract][Full Text] [Related]
14. Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation. Park KH; Ryu JH; Bae H; Yun S; Jang JH; Han K; Cho BS; Kim HJ; Lee H; Oh EJ Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455959 [TBL] [Abstract][Full Text] [Related]
15. Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation. Zhao XY; Luo XY; Yu XX; Zhao XS; Han TT; Chang YJ; Huo MR; Xu LP; Zhang XH; Liu KY; Li D; Jiang ZF; Huang XJ Br J Haematol; 2017 Jun; 177(5):766-781. PubMed ID: 28466469 [TBL] [Abstract][Full Text] [Related]
16. Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse. Luo XH; Poiret T; Liu Z; Meng Q; Nagchowdhury A; Ljungman P Front Immunol; 2022; 13():1027593. PubMed ID: 36824620 [TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440 [TBL] [Abstract][Full Text] [Related]
18. Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission. Yoon JH; Lee S; Kim HJ; Jeon YW; Lee SE; Cho BS; Lee DG; Eom KS; Kim YJ; Min CK; Cho SG; Min WS; Lee JW Oncotarget; 2016 Mar; 7(13):17230-41. PubMed ID: 26883100 [TBL] [Abstract][Full Text] [Related]
19. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279 [TBL] [Abstract][Full Text] [Related]
20. Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia. Inagaki J; Noguchi M; Kurauchi K; Tanioka S; Fukano R; Okamura J Biol Blood Marrow Transplant; 2016 Feb; 22(2):300-306. PubMed ID: 26371373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]